Search Nonprofits

The Sue DiNapoli Ovarian Cancer Society's mission is to support low income and under-insured women in Southern Colorado through the Sue’s Gift Financial Assistance Program and to educate the community about ovarian cancer symptoms and risk factors.

To raise and distribute funds to help children fighting cancer. Our primary focus for distribution of donations is to help pay for the cost of experimental cancer treatments, resources for travel to these treatments and any meals or lodging needed while receiving them.“By The Kid, for the kids!”

TO IMPROVE THE QUALITY OF LIFE OF LOCAL CANCER PATIENTS AND THEIR FAMILIES AND TO IMPROVE THE HEALTH OF THE GENERAL PUBLIC

Jazz for Prostate Cancer Awareness™ (Jazz4PCA) is a registered 501(c)(3) organization focused in raising prostate cancer awareness while raising funds for free cancer screenings. Utilizing the draw and appeal of live jazz music, Jazz4PCA’s mission is to advocate men’s wellness, with help from partnering services rendered from restaurants, music venues, notable musicians, professional healthcare practitioners, and other non-profit organizations.

The Ready or Not Foundation will endeavor to raise awareness of these important facts about pediatric brain cancer, and will succeed in its fundraising for leading research institutions seeking improved treatments and a cure. At this time, we are committed to funding Texas Children's Cancer Center Glioma Research program.

To be a place where anyone touched by cancer can find the support and resources to live life to the fullest.

Our mission is to take a direct and clinical approach to the prevention, early diagnosis and education of patients with prostate cancer. Genetic Testing Prostate cancer is genetically inherited and it is one of the main contributing factors in developing the disease. Our goal is to promote clinical and basic science research in genetic testing for the patients; their relatives and their descendants. The aim is to help the scientific world find the genetic signatures that predispose to the development of prostate cancer and use this to clinically impact those afflicted with and those predisposed based upon genetic heritage. Education for Patients and Physicians: The global impact of lack of education about prostate cancer is staggering. In the United States, most men diagnosed early with prostate cancer have a greater than 90% chance of cure. The majority of this is based upon early diagnosis from screening. This survival rate is not reflected worldwide. Educating patients on the virtues of regular prostate cancer screening along with their treatment options is one of our key missions. In addition, we support the education of physicians on the optimal treatment modalities. Global Screening Promoting the global screening for prostate cancer is a monumental task for any foundation. One of our key missions is to work with governments, organizations and programs worldwide and support their efforts in screening and education in their local environment.

The mission of the Head & Neck Cancer Foundation is to raise awareness of this disease in our community and nation. Measurable and progressive change can be accomplished by strengthening education, awareness, research, outreach and advocacy. Our ultimate goal is saving lives and improving outcomes of those affected by head and neck cancer.

TO PROVIDE EDUCATIONAL RESOURCES TO WOMEN IN THE BRAZOS VALLEY WHO HAVE BEEN NEWLY DIAGNOSED WITH BREAST CANCER.

Our mission is a comprehensive effort to increase survival rates and embrace families facing cancer in Grant County.

The Ludwig Institute for Cancer Research Ltd is committed to improving the understanding and control of cancer through integrated laboratory and clinical discovery. Leveraging its worldwide network of investigators and the ability to sponsor and conduct its own clinical trials, the Institute is actively engaged in translating its discoveries into applications for human benefit.

cc-TDI runs preclinical and translational research to identify disease-specific treatments for childhood cancers and advance promising therapies into clinical trials. The institute focuses on rare and high‑risk pediatric tumors and shares data/resources to accelerate drug development so more childhood cancers become survivable.